108 related articles for article (PubMed ID: 9269487)
1. Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling.
Kowthavarapu VK; Charbe NB; Gupta C; Iakovleva T; Stillhart C; Parrott NJ; Schmidt S; Cristofoletti R
AAPS J; 2024 Apr; 26(3):44. PubMed ID: 38575716
[TBL] [Abstract][Full Text] [Related]
2. Scientific perspectives on extending the provision for waivers of in vivo bioavailability and bioequivalence studies for drug products containing high solubility-low permeability drugs (BCS-Class 3).
Stavchansky S
AAPS J; 2008 Jun; 10(2):300-5. PubMed ID: 18512159
[TBL] [Abstract][Full Text] [Related]
3. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.
Tubic-Grozdanis M; Bolger MB; Langguth P
AAPS J; 2008; 10(1):213-26. PubMed ID: 18446522
[TBL] [Abstract][Full Text] [Related]
4. Nonclassical Zwitterions as a Design Principle to Reduce Lipophilicity without Impacting Permeability.
Möbitz H; Dittrich B; Rodde S; Strang R
J Med Chem; 2024 Jun; 67(11):9485-9494. PubMed ID: 38747896
[TBL] [Abstract][Full Text] [Related]
5. A Complete Sojourn of Current Trends in Gastro-retentive Drug Delivery System: Recent Advances and Patent Survey.
Dey A; Singh A; Kurmi BD; Singh D
Recent Pat Nanotechnol; 2024; 18(2):190-206. PubMed ID: 37005511
[TBL] [Abstract][Full Text] [Related]
6. Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development.
Markovic M; Zur M; Fine-Shamir N; Haimov E; González-Álvarez I; Dahan A
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32214015
[TBL] [Abstract][Full Text] [Related]
7. Physiologically Based Absorption Modeling to Design Extended-Release Clinical Products for an Ester Prodrug.
Ding X; Day JS; Sperry DC
AAPS J; 2016 Nov; 18(6):1424-1438. PubMed ID: 27411803
[TBL] [Abstract][Full Text] [Related]
8. Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets.
Dalton JT; Straughn AB; Dickason DA; Grandolfi GP
Pharm Res; 2001 Dec; 18(12):1729-34. PubMed ID: 11785693
[TBL] [Abstract][Full Text] [Related]
9. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.
Fleisher D; Li C; Zhou Y; Pao LH; Karim A
Clin Pharmacokinet; 1999 Mar; 36(3):233-54. PubMed ID: 10223170
[TBL] [Abstract][Full Text] [Related]
10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
11. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.
Lennernäs H
Curr Drug Metab; 2007 Oct; 8(7):645-57. PubMed ID: 17979653
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS).
Fagerholm U
J Pharm Pharmacol; 2007 Jun; 59(6):751-7. PubMed ID: 17637167
[TBL] [Abstract][Full Text] [Related]
13. The biopharmaceutic drug classification and drugs administered in extended release (ER) formulations.
Corrigan OI
Adv Exp Med Biol; 1997; 423():111-28. PubMed ID: 9269487
[TBL] [Abstract][Full Text] [Related]
14. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.
Amidon GL; Lennernäs H; Shah VP; Crison JR
Pharm Res; 1995 Mar; 12(3):413-20. PubMed ID: 7617530
[TBL] [Abstract][Full Text] [Related]
15. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
Macheras P; Iliadis A; Melagraki G
Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
